Development of lipid-based micro suspensions for ophthalmic delivery of gentaamicin

Thesis Abstract

Abstract
The use of lipid-based micro suspensions for ophthalmic drug delivery is an emerging area of research that offers significant advantages over traditional formulations. This study focuses on the development of lipid-based micro suspensions for the ophthalmic delivery of gentamicin, a broad-spectrum antibiotic commonly used in the treatment of bacterial infections of the eye. The formulation of lipid-based micro suspensions offers several key benefits for ophthalmic drug delivery. These include improved drug stability, prolonged drug release, enhanced bioavailability, and reduced frequency of administration. Lipid-based formulations also have the potential to overcome the limitations of conventional ophthalmic formulations, such as poor drug solubility and limited corneal penetration. In this study, lipid-based micro suspensions containing gentamicin were prepared using a combination of lipid materials, surfactants, and stabilizers. The formulation parameters were optimized to achieve a uniform particle size distribution and high drug loading efficiency. The physical and chemical stability of the formulations were evaluated over time to ensure long-term efficacy. The in vitro release profile of gentamicin from the lipid-based micro suspensions was studied using a modified Franz diffusion cell system. The results demonstrated sustained release of the drug over an extended period, indicating the potential for reduced dosing frequency in clinical applications. The release kinetics of gentamicin from the lipid-based micro suspensions were analyzed to determine the mechanism of drug release and optimize the formulation for therapeutic efficacy. The ocular tolerability and safety of the lipid-based micro suspensions were assessed in an in vivo rabbit eye irritation test. The results showed that the formulations were well-tolerated and did not cause any significant irritation or adverse effects, indicating their potential for clinical use. Overall, this study demonstrates the feasibility of using lipid-based micro suspensions for the ophthalmic delivery of gentamicin. The developed formulations show promise for improving the therapeutic outcomes of gentamicin treatment for ocular infections. Further research is warranted to evaluate the efficacy and safety of these formulations in clinical trials and to explore their potential for other ophthalmic drugs.